-
公开(公告)号:US5278067A
公开(公告)日:1994-01-11
申请号:US818126
申请日:1992-01-08
申请人: Michael J. Dawson , Allan Baxter , Robert M. Tait , Nigel S. Watson , David Noble , Alan Shuttleworth , Howard G. Wildman , Michael V. Hayes
发明人: Michael J. Dawson , Allan Baxter , Robert M. Tait , Nigel S. Watson , David Noble , Alan Shuttleworth , Howard G. Wildman , Michael V. Hayes
IPC分类号: A61K31/34 , A61P3/06 , A61P9/08 , A61P9/10 , A61P31/04 , C07D493/08 , C12N1/00 , C12N9/99 , C12P17/18 , C12R1/00 , C12N1/14
CPC分类号: C07D493/08 , C12P17/181 , Y10S435/911
摘要: The invention is directed to a biologically pure culture of the microorganism Phoma sp. IMI 332962 or a mutant thereof.
摘要翻译: 本发明涉及微生物Phoma sp的生物学纯培养物。 IMI 332962或其突变体。
-
公开(公告)号:US5409950A
公开(公告)日:1995-04-25
申请号:US141061
申请日:1993-10-26
申请人: Michael J. Dawson , Allan Baxter , Robert M. Tait , Nigel S. Watson , David Noble , Alan Shuttleworth , Howard G. Wildman , Michael V. Hayes
发明人: Michael J. Dawson , Allan Baxter , Robert M. Tait , Nigel S. Watson , David Noble , Alan Shuttleworth , Howard G. Wildman , Michael V. Hayes
IPC分类号: A61K31/34 , A61P3/06 , A61P9/08 , A61P9/10 , A61P31/04 , C07D493/08 , C12N1/00 , C12N9/99 , C12P17/18 , C12R1/00 , A61K31/335 , C07D311/00
CPC分类号: C07D493/08 , C12P17/181 , Y10S435/911
摘要: Compounds are described of the formula ##STR1## wherein R.sub.1 represents a hydrogen atom, a hydroxyl group or a group selected from --OCOCH.dbd.CHCH(CH.sub.3)(CH.sub.2).sub.3 CH.sub.3, --OCOCH.dbd.CHC(CH.sub.3).dbd.CHCH(CH.sub.3)--CH.sub.2 CH.sub.3, or --OCO--X--CH.sub.2 CH(CH.sub.3)CH.sub.2 CH.sub.3 [where X is --CH.dbd.CHCH(CH.sub.3)--, --CH.sub.2 CH(OH)CH(CH.sub.3)--, --CH.dbd.CHC(OH)(CH.sub.3)--, --CH.sub.2 CH(OH)CH.sub.2 -- or --CH.sub.2 CH.sub.2 CH(CH.sub.3)--)];R.sub.2 represents a hydrogen atom or a hydroxyl group;R.sub.3 represents a group selected from --C(.dbd.CH.sub.2)CH(OR.sub.7)CH(CH.sub.3)CH.sub.2 Ph (where R.sub.7 is a hydrogen atom or an acetyl group), --C(CH.sub.3).dbd.CHCH(CH.sub.2 R.sub.8)CH.sub.2 Ph (where R.sub.8 is a hydrogen or a hydroxyl group), --C(CH.sub.2 OH).dbd.CHCH(CH.sub.3)CH.sub.2 Ph, --C(.dbd.CH.sub.2)CH(OH)CH(CH.sub.2 OH)CH.sub.2 Ph, --C(.dbd.CH.sub.2)CH(NHCOCH.sub.3)CH(CH.sub.3)CH.sub.2 Ph, --C(CH.sub.2 NHCOCH.sub.3).dbd.CHCH(CH.sub.3)CH.sub.2 Ph or ##STR2## R.sub.4, R.sub.5 and R.sub.6 may each independently represent a hydrogen atom or a methyl group and salts thereof; with the proviso that when either of R.sub.1 and R.sub.2 represents a hydrogen atom R.sub.3 is a group selected from --C(.dbd.CH.sub.2)CH(OR.sub.7)CH(CH.sub.3)CH.sub.2 Ph and --C(CH.sub.3).dbd.CHCH(CH.sub.3)CH.sub.2 Ph and when both of R.sub.1 and R.sub.2 represent hydrogen atoms R.sub.3 represents --C(CH.sub.3).dbd.CHCH(CH.sub.3)CH.sub.2 Ph.These compounds inhibit the enzyme squalene synthase and/or are intermediates for the preparation of compounds which inhibit the enzyme squalene synthase. Compounds of the invention may be formulated for use in a variety of conditions where a lowering of the level of blood plasma cholesterol in animals would be beneficial and for use in combating fungal infections in animals.
摘要翻译: 描述式(I)的化合物,其中R 1表示氢原子,羟基或选自-OCOCH = CHCH(CH 3)(CH 2)3 CH 3,-OCOCH = CHC(CH 3)= CHCH(CH 3) )-CH 2 CH 3或-OCO-X-CH 2 CH(CH 3)CH 2 CH 3 [其中X是-CH = CHCH(CH 3) - , - CH 2 CH(OH)CH(CH 3) - , - CH = CHC(OH) ,-CH 2 CH(OH)CH 2 - 或-CH 2 CH 2 CH(CH 3) - )]; R2表示氢原子或羟基; R3表示选自-C(= CH2)CH(OR7)CH(CH3)CH2Ph(其中R7为氢原子或乙酰基),-C(CH3)= CHCH(CH2R8)CH2Ph(其中R8为 氢或羟基),-C(CH2OH)= CHCH(CH3)CH2Ph,-C(= CH2)CH(OH)CH(CH2OH)CH2Ph,-C(= CH2)CH(NHCOCH3)CH(CH3) ,-C(CH 2 NHCOCH 3)= CHCH(CH 3)CH 2 Ph或R 4,R 5和R 6可各自独立地表示氢原子或甲基及其盐; 条件是当R 1和R 2中的任一个表示氢原子时,R 3是选自-C(= CH 2)CH(OR 7)CH(CH 3)CH 2 Ph和-C(CH 3)= CHCH(CH 3)CH 2 Ph的基团,当两者 的R 1和R 2表示氢原子,R 3表示-C(CH 3)= CHCH(CH 3)CH 2 Ph。 这些化合物抑制角鲨烯合酶和/或用于制备抑制酶角鲨烯合酶的化合物的中间体。 本发明的化合物可以配制用于各种病症,其中动物血浆中胆固醇水平的降低将是有益的并且用于抵抗动物中的真菌感染。
-
公开(公告)号:US6054478A
公开(公告)日:2000-04-25
申请号:US836284
申请日:1997-07-16
申请人: Jose J. Martin , Jesus Chicharro Gonzalo , Jose R. R. Gomez , Silvestre Garcia-Ochoa Dorado , Federico Gomez De Las Heras , Michael V. Hayes , Michael J. Dawson , Howard G. Wildman , Richard M. Hall
发明人: Jose J. Martin , Jesus Chicharro Gonzalo , Jose R. R. Gomez , Silvestre Garcia-Ochoa Dorado , Federico Gomez De Las Heras , Michael V. Hayes , Michael J. Dawson , Howard G. Wildman , Richard M. Hall
IPC分类号: A61K31/70 , A61K31/7028 , A61P31/04 , A61P31/10 , C07H15/18 , C07H15/24 , C07H15/256 , C12P17/06 , C12P19/44 , C12R1/645 , A61K31/35 , C07D315/00
摘要: Compounds of the formula (I) ##STR1## and pharmaceutically acceptable salts or metabolically labile derivatives thereof, processes for their preparation, their use as antifungal agents and intermediates for use in their preparation.
摘要翻译: PCT No.PCT / EP95 / 04332 Sec。 371日期1997年7月16日 102(e)日期1997年7月16日PCT 1995年11月6日PCT PCT。 WO96 / 14327 PCT出版物 日期1996年5月17日式(I)化合物及其药学上可接受的盐或代谢不稳定衍生物,其制备方法,作为抗真菌剂的用途和用于其制备的中间体。
-
-